WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009802) gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009802    International Application No.:    PCT/EP2003/007730
Publication Date: 29.01.2004 International Filing Date: 16.07.2003
Chapter 2 Demand Filed:    24.01.2004    
IPC:
A61K 39/12 (2006.01), A61K 39/125 (2006.01), A61K 39/29 (2006.01), C07K 14/03 (2006.01), C07K 14/18 (2006.01), C12N 5/10 (2006.01), C12N 7/00 (2006.01), C12N 7/01 (2006.01), C12N 7/04 (2006.01), C12N 15/34 (2006.01)
Applicants: BOEHRINGER INGELHEIM VETMEDICA GMBH [DE/DE]; Binger Str. 173, 55216 Ingelheim (DE) (For All Designated States Except US).
NEUBAUER, Antonie [DE/DE]; (DE) (For US Only).
ZIEGLER, Christina [DE/DE]; (DE) (For US Only)
Inventors: NEUBAUER, Antonie; (DE).
ZIEGLER, Christina; (DE)
Common
Representative:
BOEHRINGER INGELHEIM VETMEDICA GMBH; Binger Str. 173, 55216 Ingelheim (DE)
Priority Data:
102 33 064.6 19.07.2002 DE
Title (EN) gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
(FR) MUTANTS DU VIRUS DE L'HERPES EQUIN GRAM NEGATIFS DEPOURVUS D'ELEMENTS HETEROLOGUES
Abstract: front page image
(EN)The present invention relates to the field of animal health and in particular of Equine Herpes Viruses (EHV) wherein the gene encoding the protein gM is absent, and which is free of heterologous elements. Further aspects of the invention relate to pharmaceutical compositions comprising said viruses, uses thereof, and methods for the prophylaxis and treatment of EHV infections. The invention also relates to pharmaceutical compositions comprising the combination of EHV-1 and EHV-4 viruses wherein the gene encoding the protein gM is absent and which is free of heterologous elements.
(FR)L'invention concerne le domaine de la santé animale, et en particulier les virus de l'herpès équin (VHE) dans lesquels le gène codant pour la protéine gM est absent et dépourvu d'éléments hétérologues. D'autres aspects de l'invention concernent des compositions pharmaceutiques comprenant ces virus, des applications de celles-ci et des méthodes visant à prévenir et à traiter des infections par le VHE. L'invention concerne aussi des compositions pharmaceutiques qui comprennent les virus VHE-1 et VHE-4 combinés, dans lesquels le gène qui code pour la protéine gM est absent et dépourvu d'éléments hétérologues.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)